North America Pharmaceutical Robots Market 2022-2032 by Robot Type (Articulated, Gantry, SCARA, Cylindrical, Delta, Collaborative), Application (Inspection, Packing, Pick, Lab Applications), End User (Pharmaceutical Companies, Research Labs), and Country: Trend Forecast and Growth Opportunity

North America pharmaceutical robots market is projected to grow by 9.3% annually in the forecast period and reach $104.7 million (a total revenue of hardware, software, and service) by 2032, driven by the benefits offered by pharmaceutical robots, growing awareness of robotic systems in manufacturing process, increasing investments in pharmaceutical R&D, and the stringent rules & regulations on drug safety.
Highlighted with 25 tables and 61 figures, this 116-page report "North America Pharmaceutical Robots Market 2022-2032 by Robot Type (Articulated, Gantry, SCARA, Cylindrical, Delta, Collaborative), Application (Inspection, Packing, Pick, Lab Applications), End User (Pharmaceutical Companies, Research Labs), and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire North America pharmaceutical robots market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America pharmaceutical robots market in every aspect of the classification from perspectives of Robot Type, Application, End User, and Country.

Based on Robot Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) and shipment (thousand units) for 2022-2032 included in each section.
• Articulated Robots
• Cartesian/Linear/Gantry Robots
• SCARA Robots
• Cylindrical Robots
• Delta/Parallel Robots
• Collaborative Robots
• Other Robot Types

Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) and shipment (thousand units) for 2022-2032 included in each section.
• Inspection
• Packing & Packaging
• Pick and Place
• Laboratory Applications
• Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) and shipment (thousand units) for 2022-2032 included in each section.
• Pharmaceutical Companies
• Research Labs

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) and shipment (thousand units) are available for 2022-2032. The breakdown of national markets by Robot Type, Application and End User over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
ABB Ltd.
Denso Corporation
Fanuc Corporation
Kawasaki Heavy Industries Ltd.
Kuka AG
Marchesini Group S.p.A
Mitsubishi Electric Corporation
Seiko Epson Corporation
Shibuya Corporation
Universal Robots A/S (Teradyne Inc.)
Weiss GmbH
Yaskawa Electric Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)